{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:03:24Z","timestamp":1787022204294,"version":"build-2736575974"},"update-to":[{"DOI":"10.1371\/journal.ppat.1009171","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T00:00:00Z","timestamp":1619654400000}}],"reference-count":63,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T00:00:00Z","timestamp":1618790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHSN272201400005C"],"award-info":[{"award-number":["HHSN272201400005C"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"abstract":"<jats:p>Virions are a common antigen source for many viral vaccines. One limitation to using virions is that the antigen abundance is determined by the content of each protein in the virus. This caveat especially applies to viral-based influenza vaccines where the low abundance of the neuraminidase (NA) surface antigen remains a bottleneck for improving the NA antibody response. Our systematic analysis using recent H1N1 vaccine antigens demonstrates that the NA to hemagglutinin (HA) ratio in virions can be improved by exchanging the viral backbone internal genes, especially the segment encoding the polymerase PB1 subunit. The purified inactivated virions with higher NA content show a more spherical morphology, a shift in the balance between the HA receptor binding and NA receptor release functions, and induce a better NA inhibitory antibody response in mice. These results indicate that influenza viruses support a range of ratios for a given NA and HA pair which can be used to produce viral-based influenza vaccines with higher NA content that can elicit more balanced neutralizing antibody responses to NA and HA.<\/jats:p>","DOI":"10.1371\/journal.ppat.1009171","type":"journal-article","created":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T16:13:15Z","timestamp":1618848795000},"page":"e1009171","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":27,"title":["Balancing the influenza neuraminidase and hemagglutinin responses by exchanging the vaccine virus backbone"],"prefix":"10.1371","volume":"17","author":[{"given":"Jin","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6374-0343","authenticated-orcid":true,"given":"Hongquan","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Rakic Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Klenow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5988-2920","authenticated-orcid":true,"given":"Robert","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,4,19]]},"reference":[{"issue":"3","key":"ppat.1009171.ref001","doi-asserted-by":"crossref","first-page":"734","DOI":"10.4161\/hv.27316","article-title":"Characterization of virus-like particles in GARDASIL(R) by cryo transmission electron microscopy","volume":"10","author":"Q Zhao","year":"2014","journal-title":"Hum Vaccin Immunother"},{"issue":"25","key":"ppat.1009171.ref002","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJM197206222862502","article-title":"Association of serum anti-neuraminidase antibody with resistance to influenza in man","volume":"286","author":"BR Murphy","year":"1972","journal-title":"N Engl J Med"},{"issue":"4","key":"ppat.1009171.ref003","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/infdis\/129.4.411","article-title":"Induction of partial immunity to influenza by a neuraminidase-specific vaccine","volume":"129","author":"RB Couch","year":"1974","journal-title":"J Infect Dis"},{"issue":"3","key":"ppat.1009171.ref004","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1128\/JVI.63.3.1239-1246.1989","article-title":"Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody response but induce contrasting types of immunity to infection","volume":"63","author":"BE Johansson","year":"1989","journal-title":"J Virol"},{"issue":"14","key":"ppat.1009171.ref005","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1001\/jama.297.14.1577","article-title":"Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine: a randomized controlled trial","volume":"297","author":"JJ Treanor","year":"2007","journal-title":"JAMA"},{"issue":"50","key":"ppat.1009171.ref006","doi-asserted-by":"crossref","first-page":"19123","DOI":"10.1073\/pnas.0607614103","article-title":"Influenza virus pleiomorphy characterized by cryoelectron tomography","volume":"103","author":"A Harris","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"ppat.1009171.ref007","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00742-20","article-title":"Enhancing Neuraminidase Immunogenicity of Influenza A Viruses by Rewiring RNA Packaging Signals","volume":"94","author":"A Zheng","year":"2020","journal-title":"J Virol"},{"issue":"2","key":"ppat.1009171.ref008","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1128\/JVI.70.2.873-879.1996","article-title":"The cytoplasmic tail of influenza A virus neuraminidase (NA) affects NA incorporation into virions, virion morphology, and virulence in mice but is not essential for virus replication","volume":"70","author":"LJ Mitnaul","year":"1996","journal-title":"J Virol"},{"issue":"13","key":"ppat.1009171.ref009","doi-asserted-by":"crossref","first-page":"6015","DOI":"10.1128\/JVI.74.13.6015-6020.2000","article-title":"Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus","volume":"74","author":"LJ Mitnaul","year":"2000","journal-title":"J Virol"},{"issue":"2","key":"ppat.1009171.ref010","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0168-1702(99)00131-8","article-title":"Intergenic HA-NA interactions in influenza A virus: postreassortment substitutions of charged amino acid in the hemagglutinin of different subtypes","volume":"66","author":"NV Kaverin","year":"2000","journal-title":"Virus Res"},{"issue":"2","key":"ppat.1009171.ref011","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1006\/viro.1998.9119","article-title":"Postreassortment changes in influenza A virus hemagglutinin restoring HA-NA functional match","volume":"244","author":"NV Kaverin","year":"1998","journal-title":"Virology"},{"issue":"3","key":"ppat.1009171.ref012","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/rmv.352","article-title":"Functional balance between haemagglutinin and neuraminidase in influenza virus infections","volume":"12","author":"R Wagner","year":"2002","journal-title":"Rev Med Virol"},{"issue":"3","key":"ppat.1009171.ref013","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.chom.2015.02.012","article-title":"Influenza vaccines: challenges and solutions","volume":"17","author":"K Houser","year":"2015","journal-title":"Cell host & microbe"},{"issue":"16","key":"ppat.1009171.ref014","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/S0264-410X(03)00071-9","article-title":"The annual production cycle for influenza vaccine","volume":"21","author":"C. Gerdil","year":"2003","journal-title":"Vaccine"},{"issue":"9\u201310","key":"ppat.1009171.ref015","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0264-410X(97)00279-X","article-title":"Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response","volume":"16","author":"BE Johansson","year":"1998","journal-title":"Vaccine"},{"issue":"2","key":"ppat.1009171.ref016","doi-asserted-by":"crossref","first-page":"e02556","DOI":"10.1128\/mBio.02556-14","article-title":"Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice.","volume":"6","author":"TJ Wohlbold","year":"2015","journal-title":"MBio"},{"issue":"2","key":"ppat.1009171.ref017","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cell.2018.03.030","article-title":"Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies","volume":"173","author":"YQ Chen","year":"2018","journal-title":"Cell"},{"issue":"1581","key":"ppat.1009171.ref018","article-title":"Influenza A Virus Cell Entry, Replication, Virion Assembly and Movement","volume":"9","author":"D Dou","year":"2018","journal-title":"Frontiers in Immunology"},{"issue":"19","key":"ppat.1009171.ref019","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00874-20","article-title":"N-Linked Glycan Sites on the Influenza A Virus Neuraminidase Head Domain Are Required for Efficient Viral Incorporation and Replication","volume":"94","author":"H Ostbye","year":"2020","journal-title":"J Virol"},{"issue":"23","key":"ppat.1009171.ref020","doi-asserted-by":"crossref","first-page":"9481","DOI":"10.1073\/pnas.1307473110","article-title":"Deliberate reduction of hemagglutinin and neuraminidase expression of influenza virus leads to an ultraprotective live vaccine in mice","volume":"110","author":"C Yang","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"ppat.1009171.ref021","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.1128\/JVI.00190-12","article-title":"Attenuated influenza virus construct with enhanced hemagglutinin protein expression","volume":"86","author":"J Maamary","year":"2012","journal-title":"J Virol"},{"issue":"6","key":"ppat.1009171.ref022","doi-asserted-by":"crossref","first-page":"e65955","DOI":"10.1371\/journal.pone.0065955","article-title":"Molecular signature of high yield (growth) influenza a virus reassortants prepared as candidate vaccine seeds","volume":"8","author":"M Ramanunninair","year":"2013","journal-title":"PLoS One"},{"issue":"47","key":"ppat.1009171.ref023","doi-asserted-by":"crossref","first-page":"16854","DOI":"10.1073\/pnas.1415396111","article-title":"Influenza A virus nucleoprotein selectively decreases neuraminidase gene-segment packaging while enhancing viral fitness and transmissibility","volume":"111","author":"CB Brooke","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"ppat.1009171.ref024","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1128\/JVI.03607-13","article-title":"The M segment of the 2009 pandemic influenza virus confers increased neuraminidase activity, filamentous morphology, and efficient contact transmissibility to A\/Puerto Rico\/8\/1934-based reassortant viruses","volume":"88","author":"PJ Campbell","year":"2014","journal-title":"J Virol"},{"issue":"Pt 4","key":"ppat.1009171.ref025","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1099\/jgv.0.000025","article-title":"Chimeric neuraminidase and mutant PB1 gene constellation improves growth and yield of H5N1 vaccine candidate virus","volume":"96","author":"EP Plant","year":"2015","journal-title":"J Gen Virol"},{"issue":"8","key":"ppat.1009171.ref026","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1083\/jcb.201702102","article-title":"Translational regulation of viral secretory proteins by the 5\u2019 coding regions and a viral RNA-binding protein","volume":"216","author":"J Nordholm","year":"2017","journal-title":"J Cell Biol"},{"issue":"1\u20132","key":"ppat.1009171.ref027","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jviromet.2011.08.010","article-title":"Enhanced expression of secretable influenza virus neuraminidase in suspension mammalian cells by influenza virus nonstructural protein 1","volume":"178","author":"T Nivitchanyong","year":"2011","journal-title":"Journal of virological methods"},{"issue":"2","key":"ppat.1009171.ref028","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1128\/JVI.02005-14","article-title":"The influenza virus neuraminidase protein transmembrane and head domains have coevolved","volume":"89","author":"DV da Silva","year":"2015","journal-title":"J Virol"},{"key":"ppat.1009171.ref029","article-title":"Structural restrictions for influenza neuraminidase activity promote adaptation and diversification","author":"H Wang","year":"2019","journal-title":"Nature Microbiology"},{"issue":"5","key":"ppat.1009171.ref030","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/infdis\/124.5.449","article-title":"Related studies of a recombinant influenza-virus vaccine. I. Derivation and characterization of virus and vaccine","volume":"124","author":"ED Kilbourne","year":"1971","journal-title":"J Infect Dis"},{"key":"ppat.1009171.ref031","first-page":"45","article-title":"Inactivated Viral Vaccines","author":"B Sanders","year":"2014","journal-title":"Vaccine Analysis: Strategies, Principles, and Control"},{"issue":"42","key":"ppat.1009171.ref032","doi-asserted-by":"crossref","first-page":"36198","DOI":"10.1074\/jbc.M111.279232","article-title":"Reactions of beta-propiolactone with nucleobase analogues, nucleosides, and peptides: implications for the inactivation of viruses","volume":"286","author":"JP Uittenbogaard","year":"2011","journal-title":"J Biol Chem"},{"issue":"23\u201324","key":"ppat.1009171.ref033","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1002\/pmic.201300096","article-title":"Surface modifications of influenza proteins upon virus inactivation by beta-propiolactone","volume":"13","author":"YM She","year":"2013","journal-title":"Proteomics"},{"issue":"1","key":"ppat.1009171.ref034","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.bbamem.2013.09.021","article-title":"Treatment of influenza virus with beta-propiolactone alters viral membrane fusion","volume":"1838","author":"P Bonnafous","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"ppat.1009171.ref035","article-title":"Beta-Propiolactone Inactivation of Coxsackievirus A16 Induces Structural Alteration and Surface Modification of Viral Capsids","volume":"91","author":"C Fan","year":"2017","journal-title":"J Virol"},{"issue":"1","key":"ppat.1009171.ref036","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1074\/jbc.M112.424150","article-title":"Assembly of subtype 1 influenza neuraminidase is driven by both the transmembrane and head domains","volume":"288","author":"DV da Silva","year":"2013","journal-title":"J Biol Chem"},{"issue":"8","key":"ppat.1009171.ref037","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jiac.2020.03.001","article-title":"In vitro neuraminidase inhibitory concentration (IC50) of four neuraminidase inhibitors in the Japanese 2018\u201319 season: Comparison with the 2010\u201311 to 2017\u201318 seasons","volume":"26","author":"H Ikematsu","journal-title":"J Infect Chemother. 2020"},{"issue":"19","key":"ppat.1009171.ref038","article-title":"A Single Amino Acid Substitution at Residue 218 of Hemagglutinin Improves the Growth of Influenza A(H7N9) Candidate Vaccine Viruses","volume":"93","author":"X Li","year":"2019","journal-title":"J Virol"},{"issue":"17","key":"ppat.1009171.ref039","doi-asserted-by":"crossref","first-page":"8957","DOI":"10.1128\/JVI.00592-15","article-title":"Structural Analysis of the Roles of Influenza A Virus Membrane-Associated Proteins in Assembly and Morphology","volume":"89","author":"P Chlanda","year":"2015","journal-title":"J Virol"},{"issue":"6","key":"ppat.1009171.ref040","doi-asserted-by":"crossref","first-page":"6689","DOI":"10.1021\/acsnano.9b01052","article-title":"Curvature- and Phase-Induced Protein Sorting Quantified in Transfected Cell-Derived Giant Vesicles","volume":"13","author":"G Moreno-Pescador","year":"2019","journal-title":"ACS Nano"},{"issue":"4","key":"ppat.1009171.ref041","first-page":"767","article-title":"The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses","volume":"70","author":"D Hobson","year":"1972","journal-title":"J Hyg (Lond)."},{"issue":"2","key":"ppat.1009171.ref042","doi-asserted-by":"crossref","first-page":"e00417","DOI":"10.1128\/mBio.00417-16","article-title":"Evaluation of Antihemagglutinin and Antineuraminidase Antibodies as Correlates of Protection in an Influenza A\/H1N1 Virus Healthy Human Challenge Model","volume":"7","author":"MJ Memoli","year":"2016","journal-title":"mBio"},{"issue":"21","key":"ppat.1009171.ref043","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1091\/mbc.e14-04-0874","article-title":"Type II transmembrane domain hydrophobicity dictates the cotranslational dependence for inversion","volume":"25","author":"D Dou","year":"2014","journal-title":"Mol Biol Cell"},{"issue":"15","key":"ppat.1009171.ref044","doi-asserted-by":"crossref","first-page":"10652","DOI":"10.1074\/jbc.M112.440230","article-title":"Polar residues and their positional context dictate the transmembrane domain interactions of influenza a neuraminidases","volume":"288","author":"J Nordholm","year":"2013","journal-title":"J Biol Chem"},{"issue":"49","key":"ppat.1009171.ref045","doi-asserted-by":"crossref","first-page":"33826","DOI":"10.1074\/jbc.M806897200","article-title":"The cotranslational maturation program for the type II membrane glycoprotein influenza neuraminidase","volume":"283","author":"N Wang","year":"2008","journal-title":"J Biol Chem"},{"issue":"8","key":"ppat.1009171.ref046","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1128\/JVI.69.8.5011-5017.1995","article-title":"Steps in maturation of influenza A virus neuraminidase","volume":"69","author":"T Saito","year":"1995","journal-title":"J Virol"},{"issue":"2","key":"ppat.1009171.ref047","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02332-17","article-title":"NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?","volume":"9","author":"F Krammer","year":"2018","journal-title":"mBio"},{"issue":"6027","key":"ppat.1009171.ref048","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(00)74067-0","article-title":"A NEUROTROPIC STRAIN OF HUMAN INFLUENZA VIRUS","volume":"233","author":"CH Stuart-Harris","year":"1939","journal-title":"The Lancet"},{"issue":"3","key":"ppat.1009171.ref049","first-page":"280","article-title":"The isolation and properties of a modified strain of neurotropic influenza A virus","volume":"33","author":"JC Appleby","year":"1952","journal-title":"Br J Exp Pathol"},{"issue":"1","key":"ppat.1009171.ref050","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1099\/00221287-5-1-59","article-title":"A genetic approach to variation in influenza viruses; recombination of characters in influenza virus strains used in mixed infections","volume":"5","author":"FM Burnet","year":"1951","journal-title":"J Gen Microbiol"},{"issue":"2","key":"ppat.1009171.ref051","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/0042-6822(80)90457-2","article-title":"Neurovirulence of influenza virus in mice. I. Neurovirulence of recombinants between virulent and avirulent virus strains","volume":"101","author":"A Sugiura","year":"1980","journal-title":"Virology"},{"issue":"2","key":"ppat.1009171.ref052","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0042-6822(80)90458-4","article-title":"Neurovirulence of influenza virus in mice. II. Mechanism of virulence as studied in a neuroblastoma cell line","volume":"101","author":"S Nakajima","year":"1980","journal-title":"Virology"},{"issue":"17","key":"ppat.1009171.ref053","doi-asserted-by":"crossref","first-page":"10224","DOI":"10.1073\/pnas.95.17.10224","article-title":"A novel mechanism for the acquisition of virulence by a human influenza A virus","volume":"95","author":"H Goto","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"19","key":"ppat.1009171.ref054","doi-asserted-by":"crossref","first-page":"9297","DOI":"10.1128\/JVI.75.19.9297-9301.2001","article-title":"Plasminogen-binding activity of neuraminidase determines the pathogenicity of influenza A virus","volume":"75","author":"H Goto","year":"2001","journal-title":"J Virol"},{"issue":"2","key":"ppat.1009171.ref055","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1152\/physrev.00033.2013","article-title":"Sialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regeneration","volume":"94","author":"RL Schnaar","year":"2014","journal-title":"Physiol Rev"},{"issue":"Pt 3","key":"ppat.1009171.ref056","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1099\/vir.0.18803-0","article-title":"Reverse genetics studies on the filamentous morphology of influenza A virus","volume":"84","author":"SV Bourmakina","year":"2003","journal-title":"J Gen Virol"},{"issue":"1","key":"ppat.1009171.ref057","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/viro.1997.8916","article-title":"The M1 and M2 proteins of influenza A virus are important determinants in filamentous particle formation","volume":"240","author":"PC Roberts","year":"1998","journal-title":"Virology"},{"issue":"23","key":"ppat.1009171.ref058","doi-asserted-by":"crossref","first-page":"10685","DOI":"10.1073\/pnas.1002123107","article-title":"Structural organization of a filamentous influenza A virus","volume":"107","author":"LJ Calder","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"ppat.1009171.ref059","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1750-2659.2009.00094.x","article-title":"A miniaturized assay for influenza neuraminidase-inhibiting antibodies utilizing reverse genetics-derived antigens","volume":"3","author":"MR Sandbulte","year":"2009","journal-title":"Influenza Other Respir Viruses"},{"issue":"11","key":"ppat.1009171.ref060","doi-asserted-by":"crossref","first-page":"6108","DOI":"10.1073\/pnas.100133697","article-title":"A DNA transfection system for generation of influenza A virus from eight plasmids","volume":"97","author":"E Hoffmann","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"ppat.1009171.ref061","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty percent end points","volume":"27","author":"LJ Reed","year":"1938","journal-title":"Am J Epidemiol"},{"key":"ppat.1009171.ref062","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jviromet.2014.09.003","article-title":"An optimized enzyme-linked lectin assay to measure influenza A virus neuraminidase inhibition antibody titers in human sera","volume":"210","author":"L Couzens","year":"2014","journal-title":"Journal of virological methods"},{"issue":"115","key":"ppat.1009171.ref063","article-title":"Measuring Influenza Neuraminidase Inhibition Antibody Titers by Enzyme-linked Lectin Assay. J Vis Exp","author":"J Gao","year":"2016"}],"updated-by":[{"DOI":"10.1371\/journal.ppat.1009171","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T00:00:00Z","timestamp":1619654400000}}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1009171","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T14:00:23Z","timestamp":1619704823000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1009171"}},"subtitle":[],"editor":[{"given":"Matthias Johannes","family":"Schnell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,4,19]]},"references-count":63,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1009171","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.12.08.416099","asserted-by":"object"}]},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,19]]}}}